Provided by Tiger Trade Technology Pte. Ltd.

SHANDONG XINHUA

6.640
+0.0801.22%
Volume:291.40K
Turnover:1.92M
Market Cap:4.63B
PE:9.76
High:6.640
Open:6.600
Low:6.560
Close:6.560
52wk High:9.460
52wk Low:4.895
Shares:697.00M
HK Float Shares:195.00M
Volume Ratio:0.22
T/O Rate:0.15%
Dividend:0.27
Dividend Rate:4.11%
EPS(LYR):0.680
ROE:7.59%
ROA:3.06%
PB:0.79
PE(LYR):9.76
PS:0.48

Loading ...

AH Share Premium Rate and Deviation Rankings as of December 3

Stock News
·
Dec 03, 2025

AH Share Premium Rate Rankings as of December 1

Stock News
·
Dec 01, 2025

Shandong Xinhua Pharmaceutical (00719) Announces Monthly Return for November 2025

Bulletin Express
·
Dec 01, 2025

AH Share Premium Rate and Deviation Rankings as of November 28

Stock News
·
Nov 28, 2025

Xinhua Pharmaceutical Gets China Nod for Inflammatory Disease Drug-Related Marketing

MT Newswires Live
·
Nov 27, 2025

Xinhua Pharmaceutical's Dyspnea Drug Passes Chinese Regulator's Consistency Evaluation

MT Newswires Live
·
Nov 27, 2025

Xinhua Pharmaceutical (00719.HK / 000756.SZ) Announces Epinephrine Hydrochloride Injection Passes Generic Consistency Evaluation

Bulletin Express
·
Nov 27, 2025

Xinhua Pharmaceutical (00719.HK/000756.SZ) Receives Approval for Prednisolone Acetate

Bulletin Express
·
Nov 27, 2025

SHANDONG XINHUA (00719) Receives Approval Notice for Prednisolone Acetate API Marketing Application

Stock News
·
Nov 27, 2025

AH Premium Rate and Deviation Rankings as of November 26

Stock News
·
Nov 26, 2025

Xinhua Pharmaceutical Obtains Registration Certificate for Local Skin Anesthesia Drug

MT Newswires Live
·
Nov 25, 2025

HK Stock Movement | SHANDONG XINHUA (00719) Rises Over 4% as Lidocaine and Prilocaine Cream Gains Approval

Stock News
·
Nov 25, 2025

Here's Why Shandong Xinhua Pharmaceutical (HKG:719) Can Manage Its Debt Responsibly

Simply Wall St.
·
Nov 22, 2025

Xinhua Pharmaceutical (HKEx: 00719, SZSE: 000756) Gains Approval for Vonoprazan Fumarate API

Bulletin Express
·
Nov 17, 2025

SHANDONG XINHUA (00719) Receives Approval Notice for Vonoprazan Fumarate API Marketing Application

Stock News
·
Nov 17, 2025

Southbound Stock Connect Fund Flow (T+2) | Nov 17

Stock News
·
Nov 17, 2025

Xinhua Pharmaceutical Gets Registration Certificate for Osteoporosis Drug

MT Newswires Live
·
Oct 31, 2025

Xinhua Pharmaceutical (00719.HK, 000756.SZ) Secures Drug Registration Certificate for Alendronate Sodium Oral Solution

Bulletin Express
·
Oct 31, 2025

SHANDONG XINHUA (00719) Receives NMPA Approval for Alendronate Sodium Oral Solution

Stock News
·
Oct 31, 2025

AH Premium Rate Statistics as of October 27

Stock News
·
Oct 27, 2025